CAS: 875446-37-0 - (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-{[4'-fluoro-2'-methoxy-5'-(propan-2-yl)-4-(trifluoromethyl)biphenyl-2-yl]methyl}-4-methyl-1,3-oxazolidin-2-one

Formule : C₃₀H₂₅F₁₀NO₃

InChI : InChI=1S/C30H25F10NO3/c1-14(2)22-11-23(25(43-4)12-24(22)31)21-6-5-18(28(32,33)34)9-17(21)13-41-15(3)26(44-27(41)42)16-7-19(29(35,36)37)10-20(8-16)30(38,39)40/h5-12,14-15,26H,13H2,1-4H3/t15-,26-/m0/s1

Code InChI : InChIKey=MZZLGJHLQGUVPN-HAWMADMCSA-N

SMILES : O=C1OC(C=2C=C(C=C(C2)C(F)(F)F)C(F)(F)F)C(N1CC3=CC(=CC=C3C=4C=C(C(F)=CC4OC)C(C)C)C(F)(F)F)C

Synonymes :

• (4S,5R)-5-[3,5-Bis(trifluoromethyl)phenyl]-3-[[4′-fluoro-2′-methoxy-5′-(1-methylethyl)-4-(trifluoromethyl)[1,1′-biphenyl]-2-yl]methyl]-4-methyl-2-oxazolidinone
• (4S,5R)-5-[3,5-Bis(trifluoromethyl)phenyl]-3-[[4′-fluoro-5′-isopropyl-2′-methoxy-4-(trifluoromethyl)biphenyl-2-yl]methyl]-4-methyl-1,3-oxazolidin-2-one
• 2-Oxazolidinone, 5-[3,5-bis(trifluoromethyl)phenyl]-3-[[4′-fluoro-2′-methoxy-5′-(1-methylethyl)-4-(trifluoromethyl)[1,1′-biphenyl]-2-yl]methyl]-4-methyl-, (4S,5R)-
• Anacetrapib
• Anacetrapib (With 3 Ints.)
• Anacetrpib
• Mk 0859

(4S,5R)-5-[3,5-Bis(trifluoromethyl)phenyl]-3-[[4'-fluoro-5'-isopropyl-2'-methoxy-4-(trifluoromethyl)biphenyl-2-yl]methyl]-4-methyl-1,3-oxazolidin-2-one

CAS : 875446-37-0

• Formule : C₃₀H₂₅F₁₀NO₃
• Degré de pureté : 98%
• Couleur et forme : Solid
• Masse moléculaire : 637.5084

Anacetrapib

CAS : 875446-37-0

• Formule : C₃₀H₂₅F₁₀NO₃
• Masse moléculaire : 637.51

Anacetrapib

CAS : 875446-37-0

Anacetrapib (MK-0859) inhibits rhCETP/CETP(C13S) (IC50: 7.9/11.8 nM), boosts HDL, lowers LDL cholesterol.

• Formule : C₃₀H₂₅F₁₀NO₃
• Degré de pureté : 97.09% - 99.62%
• Couleur et forme : Solid
• Masse moléculaire : 637.51

Anacetrapib

CAS : 875446-37-0

A potent inhibitor of CETP that inhibits transfer of cholesteryl esters and triglycerides. Raises HDL …

• Formule : C₃₀H₂₅F₁₀NO₃
• Degré de pureté : Min. 95%
• Couleur et forme : Powder
• Masse moléculaire : 637.51 g/mol